• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

NHS Scotland - Articles and news items

NHS Scotland approves Novo Nordisk’s diabetes drug

Industry news / 9 August 2016 / Novo Nordisk

The drug was approved using evidence from three phase III studies in adults with type 1 diabetes mellitus and five phase III studies in adults with type 2 diabetes mellitus. The researchers discovered that insulin degludec was non-inferior to other long-acting insulin analogues, assessed by the mean change in glycosylated haemoglobin (HbA1c)…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +